Pharma report, Pharmaceutical Analysis and Development (R&D) – Increasing Efficency By means of Information Technology and Externalization offers key information, info and analysis on main pharmaceutical R&D practices at the worldwide level in order to boost its efficiency and effectiveness. This pharmaceutical and healthcare report gives extensive insight into the major challenges in the current pharmaceutical R&D landscape. It analyzes crucial measures and practices (mergers and acquisitions, R&D restructuring, outsourcing and active lifecycle management) adopted by the pharmaceutical market to tackle these challenges and enhance the R&D efficiency. The report substantiates the evaluation with a variety of case studies to study the impact of measure post-implementation. The report also supplies an analytical insight into the possible options that have tremendous potential to increase the future pharmaceutical and biotech R&D productivity.
The pharmaceutical business has witnessed a considerable decline in R&D productivity over the past handful of years, which has grow to be a matter of concern amongst the important stakeholders in the sector, especially the pharmaceutical organizations. While the R&D expenditure of the industry has steadily elevated, the output has been declining. The boost in the quantity of late-stage development failures is costing the pharmaceutical business dearly. In addition, the stringent regulatory mechanisms on the pricing and reimbursement of approved drugs have added to the stress. Pharmaceutical firms have attempted many techniques to increase the R&D efficiency which contain the acquisitions of little biotechnology and pharmaceutical firms, R&D restructuring, outsourcing and greater lifecycle management of their current drugs in the market place. Nonetheless, there has been restricted achievement achieved to date.
This report is built making use of information and details sourced from proprietary databases, main and secondary research and in property evaluation by group of sector specialists.
The report analyses the crucial measures adopted to increase the R&D efficiency in the pharmaceutical and biotech industry along with the main challenges that have led to a decrease in the R&D productivity over the final decade. The scope of the report involves:
– Major challenges in the current pharmaceutical R&D landscape.
– Key options adopted by the pharmaceutical industry to improve the R&D productivity which consist of strategic mergers and acquisitions, R&D restructuring, outsourcing and active lifecycle management.
– More than 25 examples and case studies explaining each and every resolution and its influence on the R&D productivity in a short and extended term.
– Qualitative evaluation of the main potential solutions that can boost the R&D productivity in the future.
For more data, please pay a visit to :
http://www.aarkstore.com/reports/Pharmaceutical-Study-and-Improvement-R-D-Increasing-Efficiency-by way of-Information-Technologies-and-Externalization-45336.html
Other people Reports
The Future of Anesthesia and Respiratory Devices, Competitive Landscape and Forecasts to 2016 – Home and Self Care Respiratory Devices Presenting Growth Avenues
The Future of the Oil Fields Services Industry to 2015 Rebound in Exploration and Drilling Activity Drives Growth
The Future of Clean Technology Markets to 2020-Marketplace Forecasts, Deal Evaluation and Investment Possibilities
The Future of Ophthalmic Devices, Market Forecasts and Development Possibilities to 2016 – The Vision Care Segment Emerges as a Crucial Revenue Generator
The Future of the Property Healthcare Equipment Industry to 2016 – Market Forecasts, Competitive Landscape and Pipeline Evaluation
The Future of Discomfort Management Therapeutics, Evaluation and Market place Forecasts to 2016 – Growing Generic Competitors Creates Challenges
The Future of Dermatology Therapeutics, Evaluation and Market place Forecasts to 2016 – Growing Prescription Price to Drive Revenues